Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$36.45 - $47.7 $3.4 Million - $4.44 Million
93,182 Added 140.12%
159,685 $7.61 Million
Q1 2024

May 13, 2024

BUY
$42.03 - $53.55 $2.8 Million - $3.56 Million
66,503 New
66,503 $2.88 Million
Q3 2023

Nov 13, 2023

BUY
$38.5 - $47.13 $4.2 Million - $5.14 Million
109,117 Added 1990.1%
114,600 $5.2 Million
Q2 2023

Aug 11, 2023

BUY
$34.73 - $43.33 $190,424 - $237,578
5,483 New
5,483 $224,000
Q2 2022

Aug 12, 2022

BUY
$31.71 - $43.0 $428,750 - $581,403
13,521 Added 12.36%
122,897 $4.55 Million
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $3.27 Million - $4.05 Million
109,376 New
109,376 $4.05 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $3.28 Million - $4.5 Million
-128,087 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $4.3 Million - $5.19 Million
128,087 New
128,087 $4.3 Million
Q1 2021

May 17, 2021

SELL
$42.51 - $63.78 $2.06 Million - $3.09 Million
-48,427 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $2.19 Million - $2.92 Million
48,427 New
48,427 $2.74 Million
Q3 2020

Nov 13, 2020

SELL
$47.45 - $62.95 $1.03 Million - $1.36 Million
-21,624 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $1.01 Million - $1.32 Million
21,624 New
21,624 $1.27 Million
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $2.95 Million - $3.58 Million
-54,813 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$59.06 - $72.15 $3.24 Million - $3.95 Million
54,813 New
54,813 $3.28 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.